July 11, 2014
July 11, 2014
Researchers are approaching the problem of Ras from a number of different angles – directly attacking the protein, disrupting its signaling and focusing on targets that are triggered by Ras.
July 7, 2014
Pharmaceutical, biotech and academic laboratories long have tried to develop drugs to target Ras. Most of the efforts focused on K-Ras, which is one of the three different types, or “isoforms,” of Ras – the others are N-Ras and H-Ras – and is the most
June 27, 2014
When Todd and Lisa Harris were informed that their 10-month-old son Evan had cancer, they were very upset, but they also felt as if a weight had been lifted. “At least now we had an answer, albeit an extremely painful one, and a path forward,” Lisa Harris said about her son’s diagnosis at the time.
June 25, 2014
June 18, 2014
It’s one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Now, buoyed by recent research breakthroughs and funding support, scientists are pushing harder than ever to target what has been called "undruggable."
June 8, 2014
June 1, 2014
Research led by a UC San Francisco investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
May 29, 2014
From prostate cancer to immunotherapy to genetic testing, UC San Francisco research is providing new insights and aiding in the development of new treatment strategies for cancer.
May 27, 2014
A UC San Francisco professor of biochemistry and biophysics has received Asia’s highest scientific honor, the 2014 Shaw Prize in Life Science and Medicine, for his groundbreaking discovery of a system that makes "life and death decisions" for the cell.